No abstract available.
Intracranial Thrombosis*

No abstract available.
Polycythemia* ; Sinus Thrombosis, Intracranial*

The most important assets of a responsible and successful neuro-endovascular surgeon are knowledge of the possible technical difficulties, complications that may be encountered during the procedures. The intrinsic risks of complications involved with GDC embolization for cerebral aneurysms are multifactorial; the experience and skill of the physician, the different kind of devices used and geometry of aneurysm. Any complication can be totally unpredictable and even unknown for a time. Duration of the procedures another critical factor, so some of the complications (eg., vascular damage, thrombosis, intimal damage) is simply from the length of the procedure.
Aneurysm* ; Intracranial Aneurysm ; Thrombosis

It is well known that spontaneous thrombosis in giant cerebral aneurysm is common. However, spontaneous obliteration of a non-giant and unruptured cerebral aneurysm has been reported to be rare and its pathogenic mechanism is not clear. We describe a case with rare vascular phenomenon and review the relevant literatures.
Intracranial Aneurysm ; Thrombosis

Reports of thrombosis and recanalization of cerebral aneurysm are rare. We report two cases of small, saccular aneurysms in which spontaneous thrombosis had occurred during the preparation for endovascular coiling. Also, we review reported cases and propose the presumed pathogenesis.
Aneurysm ; Intracranial Aneurysm* ; Thrombosis*

Thrombosis of the dural sinus in the fetal period is an extremely rare congenital cerebrovascular condition. The exact etiologies and prognosis of dural sinus thrombosis in the fetal period are still unknown due to the extremely limited clinical information available. Therefore, we present a case of dural sinus thrombosis diagnosed by prenatal ultrasound and fetal magnetic resonance imaging that spontaneously regressed, with a brief review of the relevant literature.
Magnetic Resonance Imaging ; Prenatal Diagnosis ; Prognosis ; Sinus Thrombosis, Intracranial ; Thrombosis

Immunoglobulin G4-related hypertrophic pachymeningitis (IgG4-RHP) is an increasingly recognized manifestation of IgG4-related disease (IgG4-RD), which is a fibroinflammatory condition that can affect virtually any organ. The three hallmark histopathological features of IgG4-RD are lymphoplasmacytic infiltration of IgG4-positive plasma cells, storiform fibrosis, and obliterative phlebitis. We report a case of biopsy-confirmed IgG4-RHP that was initially misdiagnosed as cerebral venous thrombosis.
Fibrosis ; Immunoglobulins ; Intracranial Thrombosis ; Meningitis ; Phlebitis ; Plasma Cells ; Venous Thrombosis

We measured plasma B-Endorphin in 10 patients with cerebral thrombosis, with comparing normal control group and obtained the following results. 1. The mean value of plasma B-Endorphin was 6.173+0.335 pmol/l in normal control male group and 4.55+0.443 pmol/l in normal control female group. 2. The level of plasma B-Endorphin was increased as mean value was 29.2 pmol/o in acute phase of cerebral thrombosis and it showed significant statistical difference. 3. Measurement on convalescent phase in patient with cerebral thrombosis also increased significantly compared with normal control group, but reduced significantly compared with patients in acute phase.
Female ; Humans ; Intracranial Thrombosis* ; Male ; Plasma*

Since opening of the Yeungnam University Hospital in June 1983 till end of 1984, total 30 cases of cerebral thrombosis were analyzed clinically. Among the 30. 17 cases were given Urokinase from 60,000 to 240,000 units daily for 2-46 days. The interval from the onset to the inititiation of therapy varied from 1 hour to 17 days. Ten cases showed marked recovery and 6 cases moderate improvement. One case, in which only 120,000 units daily were administered, showed stationary course. The interval of the Urokinase untreated 13 cases was from 3 days to 18 months. Six cases were sationary, whereas 7 cases showed mild improvement. Age, sex, past history, associated diseases, and the laboratory findings are shown in the tables. Conclusion is that the earlier the therapy started, the higher the dosage used, the better of the results is obtained.
Intracranial Thrombosis* ; Urokinase-Type Plasminogen Activator*

No abstract available.
Clomiphene ; Humans ; Infertility* ; Male* ; Sinus Thrombosis, Intracranial*